Stocks and Investing Stocks and Investing
Thu, May 23, 2024
Wed, May 22, 2024

Brooks O"Neil Maintained (TNDM) at Strong Buy with Increased Target to $75 on, May 22nd, 2024


Published on 2024-10-28 11:32:32 - WOPRAI, Brooks O'Neil
  Print publication without navigation


Brooks O"Neil of Lake Street, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Strong Buy with Increased Target from $60 to $75 on, May 22nd, 2024.

Brooks has made no other calls on TNDM in the last 4 months.

There are 6 other peers that have a rating on TNDM. Out of the 6 peers that are also analyzing TNDM, 2 agree with Brooks"s Rating of Hold. Following are those relevant analyst calls for the last 4 months;

Jeff Johnson of "Baird" Maintained at Hold with Increased Target to $36 on, Friday, May 3rd, 2024
Rick Wise of "Stifel" Maintained at Hold with Increased Target to $24 on, Monday, February 5th, 2024

These are the ratings of the 4 analyists that currently disagree with Brooks;

Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $55 on, Monday, May 6th, 2024
Matt O"Brien of "Piper Sandler" Reiterated at Buy with Increased Target to $50 on, Friday, May 3rd, 2024
Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $50 on, Friday, May 3rd, 2024
Mike Kratky of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $45 on, Thursday, April 25th, 2024

Contributing Sources